Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsEbitda growth

    Ebitda Growth

    Jump to

    • Bank of Baroda, L&T, Biocon, IndusInd Bank, Nestle India| Stocks On Radar

      Bank of Baroda Q3 results: Net profit rises 5.6% to Rs 4,837 crore, NII up 3%. L&T Q3 results: Net profit rises 14% to Rs 3,359 crore, but misses estimates as EBITDA margins fall. Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%. IndusInd Bank Q3 Preview: Profit may see sharp 39% YoY fall amid rising slippages. Nestle India Q3 Preview: Net profit may slip 9% on increased competition

    • Expect 19-20% growth in FY17: Aarti Industries

      The company's EBITDA may grow 15-20 percent next fiscal on the back of low raw material cost, says Rajendra Gogri, CMD, Aarti Industries.

    • See margin expansion for Asian Paints; remain a top pick: Pros

      The company's Q3 net profit jumped 25.8 percent to Rs 463 crore from Rs 368 crore in corresponding quarter last fiscal. However, exceptional hit partially mitigated profit growth.

    • Eyeing EBITDA growth of 35% for FY15: Jyothy Laboratories

      The company is also aiming for a top line growth of 18-20 percent for FY15.

    • CARE maintains fundamental grade of 3/5 on Elder Pharma

      CARE Equity Research has come out with its report on Elder Pharmaceuticals Limited (EPL). The research firm has maintained the fundamental grade of 3/5 on the company, which indicates ‘Good Fundamentals’.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347